Holen Sie sich die Stockscreener-App
4.84
2.97%
-0.21
Schlusskurs vom Vortag:
$5.05
Offen:
$5.071
24-Stunden-Volumen:
59,591
Relative Volume:
0.55
Marktkapitalisierung:
$332.45M
Einnahmen:
$64.49M
Nettoeinkommen (Verlust:
$-71.40M
KGV:
-4.4404
EPS:
-1.09
Netto-Cashflow:
$-52.00M
1W Leistung:
-0.41%
1M Leistung:
+8.41%
6M Leistung:
+60.66%
1J Leistung:
+46.71%
1-Tages-Spanne:
$4.765
$5.071
1-Wochen-Bereich:
$4.54
$5.29
52-Wochen-Spanne:
$2.58
$5.30
Sophia Genetics Sa Stock (SOPH) Company Profile
Firmenname
Sophia Genetics Sa
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SOPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
4.90 | 340.59M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
243.91 | 39.83B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.69 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.94 | 9.66B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.39 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.45 | 6.77B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-03 | Eingeleitet | BTIG Research | Buy |
| 2022-11-23 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Cowen | Outperform |
| 2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-17 | Eingeleitet | JP Morgan | Overweight |
| 2021-08-17 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten
321,527 Shares in SOPHiA GENETICS SA $SOPH Purchased by Archon Capital Management LLC - Defense World
SOPHiA GENETICS : Tyrolpath Adopts MSK-IMPACT®-Flex powered with SOPHiA DDM™ to Expand Precision Oncology in Austria - marketscreener.com
Is SOPHiA GENETICS SA (90B) stock vulnerable to rate hikesQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Can SOPHiA GENETICS SA stock sustain free cash flow growthWeekly Trend Recap & Real-Time Buy Signal Alerts - Newser
Can SOPHiA GENETICS SA stock resist market sell offs2025 Market Overview & Technical Confirmation Alerts - Newser
Why hedge funds are buying SOPHiA GENETICS SA stock2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
Can SOPHiA GENETICS SA (90B) stock sustain institutional flows2025 Year in Review & Fast Entry High Yield Stock Tips - Newser
Is SOPHiA GENETICS SA a good long term investmentShort-Term Trading Alerts & Rapid Portfolio Trading - earlytimes.in
Sophia Genetics (SOPH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Ensign Peak Advisors Inc Takes $775,000 Position in SOPHiA GENETICS SA $SOPH - MarketBeat
Can SOPHiA GENETICS SA stock maintain growth trajectoryJuly 2025 Retail & Consistent Profit Trading Strategies - moha.gov.vn
Revenue per share of SOPHiA GENETICS SA – FWB:90B - TradingView
SOPHiA GENETICS SA (SOPH) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
EBITDA per share of SOPHiA GENETICS SA – FWB:90B - TradingView
Why SOPHiA GENETICS SA (90B) stock attracts wealthy investors2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Is SOPHiA GENETICS SA (90B) stock bottoming after sell offShare Buyback & Consistent Return Strategy Ideas - newser.com
Will SOPHiA GENETICS SA stock outperform growth indexes - newser.com
How SOPHiA GENETICS SA stock performs in rate cut cyclesEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Will SOPHiA GENETICS SA (90B) stock deliver stable dividendsWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
Why SOPHiA GENETICS SA (90B) stock could be top winnerMarket Sentiment Review & Long-Term Safe Return Strategies - newser.com
Applying big data sentiment scoring on SOPHiA GENETICS SAJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
Can a trend reversal in SOPHiA GENETICS SA lead to recoveryRate Hike & Fast Gaining Stock Reports - newser.com
Why SOPHiA GENETICS SA (90B) stock could rally stronglyTrade Performance Summary & Precise Buy Zone Tips - newser.com
What is the fair value estimate for SOPHiA GENETICS SA (90B) stock in 2025July 2025 Review & Target Return Focused Picks - newser.com
How SOPHiA GENETICS SA (90B) stock benefits from digital adoptionAnalyst Upgrade & Free Real-Time Market Sentiment Alerts - newser.com
Why SOPHiA GENETICS SA stock remains a top recommendationLong Setup & Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-11-19 02:05:46 - newser.com
Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.65%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):